The VHL gene is epigenetically inactivated in pheochromocytomas and abdominal paragangliomas

References

• DeLellis R. Pathology and genetics of tumours of endocrine organs. Lyon: IARC Press; 2004. 136–166 p.
   Google Scholar
• Bravo EL, Gifford RW Jr.. Current concepts. Pheochromocytoma: diagnosis, localization and management. N Engl J Med 1984; 311:1298 - 303; http://dx.doi.org/10.1056/NEJM198411153112007; PMID: 6149463
   PubMed Web of Science ®Google Scholar
• Sutton MG, Sheps SG, Lie JT. Prevalence of clinically unsuspected pheochromocytoma. Review of a 50-year autopsy series. Mayo Clin Proc 1981; 56:354 - 60; PMID: 6453259
   PubMed Web of Science ®Google Scholar
• Neumann HPH, Bausch B, McWhinney SR, Bender BU, Gimm O, Franke G, Schipper J, Klisch J, Altehoefer C, Zerres K, et al, Freiburg-Warsaw-Columbus Pheochromocytoma Study Group. Germ-line mutations in nonsyndromic pheochromocytoma. N Engl J Med 2002; 346:1459 - 66; http://dx.doi.org/10.1056/NEJMoa020152; PMID: 12000816
   PubMed Web of Science ®Google Scholar
• Jafri M, Maher ER. The genetics of phaeochromocytoma: using clinical features to guide genetic testing. Eur J Endocrinol 2012; 166:151 - 8; http://dx.doi.org/10.1530/EJE-11-0497; PMID: 21896620
   PubMed Web of Science ®Google Scholar
• Yeh I-T, Lenci RE, Qin Y, Buddavarapu K, Ligon AH, Leteurtre E, Do Cao C, Cardot-Bauters C, Pigny P, Dahia PLM. A germline mutation of the KIF1B beta gene on 1p36 in a family with neural and nonneural tumors. Hum Genet 2008; 124:279 - 85; http://dx.doi.org/10.1007/s00439-008-0553-1; PMID: 18726616
   PubMed Web of Science ®Google Scholar
• Bayley J-P, Kunst HPM, Cascon A, Sampietro ML, Gaal J, Korpershoek E, Hinojar-Gutierrez A, Timmers HJLM, Hoefsloot LH, Hermsen MA, et al. SDHAF2 mutations in familial and sporadic paraganglioma and phaeochromocytoma. Lancet Oncol 2010; 11:366 - 72; http://dx.doi.org/10.1016/S1470-2045(10)70007-3; PMID: 20071235
   PubMed Web of Science ®Google Scholar
• Astuti D, Ricketts CJ, Chowdhury R, McDonough MA, Gentle D, Kirby G, Schlisio S, Kenchappa RS, Carter BD, Kaelin WG Jr., et al. Mutation analysis of HIF prolyl hydroxylases (PHD/EGLN) in individuals with features of phaeochromocytoma and renal cell carcinoma susceptibility. Endocr Relat Cancer 2011; 18:73 - 83; http://dx.doi.org/10.1677/ERC-10-0113; PMID: 20959442
   PubMed Web of Science ®Google Scholar
• Comino-Méndez I, de Cubas AA, Bernal C, Álvarez-Escolá C, Sánchez-Malo C, Ramírez-Tortosa CL, Pedrinaci S, Rapizzi E, Ercolino T, Bernini G, et al. Tumoral EPAS1 (HIF2A) mutations explain sporadic pheochromocytoma and paraganglioma in the absence of erythrocytosis. Hum Mol Genet 2013; 22:2169 - 76; http://dx.doi.org/10.1093/hmg/ddt069; PMID: 23418310
   PubMed Web of Science ®Google Scholar
• Burnichon N, Buffet A, Parfait B, Letouzé E, Laurendeau I, Loriot C, Pasmant E, Abermil N, Valeyrie-Allanore L, Bertherat J, et al. Somatic NF1 inactivation is a frequent event in sporadic pheochromocytoma. Hum Mol Genet 2012; 21:5397 - 405; http://dx.doi.org/10.1093/hmg/dds374; PMID: 22962301
   PubMed Web of Science ®Google Scholar
• Welander J, Larsson C, Bäckdahl M, Hareni N, Sivlér T, Brauckhoff M, Söderkvist P, Gimm O. Integrative genomics reveals frequent somatic NF1 mutations in sporadic pheochromocytomas. Hum Mol Genet 2012; 21:5406 - 16; http://dx.doi.org/10.1093/hmg/dds402; PMID: 23010473
   PubMed Web of Science ®Google Scholar
• Geli J, Kiss N, Karimi M, Lee J-J, Bäckdahl M, Ekström TJ, Larsson C. Global and regional CpG methylation in pheochromocytomas and abdominal paragangliomas: association to malignant behavior. Clin Cancer Res 2008; 14:2551 - 9; http://dx.doi.org/10.1158/1078-0432.CCR-07-1867; PMID: 18451216
   PubMed Web of Science ®Google Scholar
• Kiss NB, Muth A, Andreasson A, Juhlin CC, Geli J, Bäckdahl M, Höög A, Wängberg B, Nilsson O, Ahlman H, et al. Acquired hypermethylation of the P16INK4A promoter in abdominal paraganglioma: relation to adverse tumor phenotype and predisposing mutation. Endocr Relat Cancer 2013; 20:65 - 78; http://dx.doi.org/10.1530/ERC-12-0267; PMID: 23154831
   PubMed Web of Science ®Google Scholar
• Letouzé E, Martinelli C, Loriot C, Burnichon N, Abermil N, Ottolenghi C, Janin M, Menara M, Nguyen AT, Benit P, et al. SDH mutations establish a hypermethylator phenotype in paraganglioma. Cancer Cell 2013; 23:739 - 52; http://dx.doi.org/10.1016/j.ccr.2013.04.018; PMID: 23707781
   PubMed Web of Science ®Google Scholar
• Cascon A, Ruiz-Llorente S, Fraga MF, Leton R, Telleria D, Sastre J, Diez JJ, Martinez Diaz-Guerra G, Diaz Perez JA, Benitez J, et al. Genetic and epigenetic profile of sporadic pheochromocytomas. J Med Genet 2004; 41:e30; http://dx.doi.org/10.1136/jmg.2003.012658; PMID: 14985401
   PubMed Web of Science ®Google Scholar
• Dammann R, Schagdarsurengin U, Seidel C, Trümpler C, Hoang-Vu C, Gimm O, Dralle H, Pfeifer GP, Brauckhoff M. Frequent promoter methylation of tumor-related genes in sporadic and men2-associated pheochromocytomas. Exp Clin Endocrinol Diabetes 2005; 113:1 - 7; http://dx.doi.org/10.1055/s-2004-830522; PMID: 15662588
   PubMed Web of Science ®Google Scholar
• Feinberg AP, Vogelstein B. Hypomethylation distinguishes genes of some human cancers from their normal counterparts. Nature 1983; 301:89 - 92; http://dx.doi.org/10.1038/301089a0; PMID: 6185846
   PubMed Web of Science ®Google Scholar
• Valera VA, Walter BA, Linehan WM, Merino MJ. Regulatory Effects of microRNA-92 (miR-92) on VHL Gene Expression and the Hypoxic Activation of miR-210 in Clear Cell Renal Cell Carcinoma. J Cancer 2011; 2:515 - 26; http://dx.doi.org/10.7150/jca.2.515; PMID: 22043236
   PubMed Web of Science ®Google Scholar
• Moore LE, Nickerson ML, Brennan P, Toro JR, Jaeger E, Rinsky J, Han SS, Zaridze D, Matveev V, Janout V, et al. Von Hippel-Lindau (VHL) inactivation in sporadic clear cell renal cancer: associations with germline VHL polymorphisms and etiologic risk factors. PLoS Genet 2011; 7:e1002312; http://dx.doi.org/10.1371/journal.pgen.1002312; PMID: 22022277
   PubMed Web of Science ®Google Scholar
• Elkahloun AG, Powers JF, Nyska A, Eisenhofer G, Tischler AS. Gene expression profiling of rat pheochromocytoma. Ann N Y Acad Sci 2006; 1073:290 - 9; http://dx.doi.org/10.1196/annals.1353.033; PMID: 17102098
   PubMed Web of Science ®Google Scholar
• Waldmann J, Fendrich V, Holler J, Buchholz M, Heinmöller E, Langer P, Ramaswamy A, Samans B, Walz MK, Rothmund M, et al. Microarray analysis reveals differential expression of benign and malignant pheochromocytoma. Endocr Relat Cancer 2010; 17:743 - 56; http://dx.doi.org/10.1677/ERC-09-0118; PMID: 20562231
   PubMed Web of Science ®Google Scholar
• Eisenhofer G, Huynh T-T, Pacak K, Brouwers FM, Walther MM, Linehan WM, Munson PJ, Mannelli M, Goldstein DS, Elkahloun AG. Distinct gene expression profiles in norepinephrine- and epinephrine-producing hereditary and sporadic pheochromocytomas: activation of hypoxia-driven angiogenic pathways in von Hippel-Lindau syndrome. Endocr Relat Cancer 2004; 11:897 - 911; http://dx.doi.org/10.1677/erc.1.00838; PMID: 15613462
   PubMed Web of Science ®Google Scholar
• Dahia PLM, Ross KN, Wright ME, Hayashida CY, Santagata S, Barontini M, Kung AL, Sanso G, Powers JF, Tischler AS, et al. A HIF1alpha regulatory loop links hypoxia and mitochondrial signals in pheochromocytomas. PLoS Genet 2005; 1:72 - 80; http://dx.doi.org/10.1371/journal.pgen.0010008; PMID: 16103922
   PubMed Web of Science ®Google Scholar
• Thouënnon E, Elkahloun AG, Guillemot J, Gimenez-Roqueplo A-P, Bertherat J, Pierre A, Ghzili H, Grumolato L, Muresan M, Klein M, et al. Identification of potential gene markers and insights into the pathophysiology of pheochromocytoma malignancy. J Clin Endocrinol Metab 2007; 92:4865 - 72; http://dx.doi.org/10.1210/jc.2007-1253; PMID: 17878247
   PubMed Web of Science ®Google Scholar
• Lack EE. Tumors of the adrenal glands and extraadrenal paraganglia. Washington DC, USA: American Registry of Pathology in collaboration with the Armed Forces Institute of Pathology. 2007. 274–276 p.
   Google Scholar
• Sulaiman L, Juhlin CC, Nilsson I-L, Fotouhi O, Larsson C, Hashemi J. Global and gene-specific promoter methylation analysis in primary hyperparathyroidism. Epigenetics 2013; 8:646 - 55; http://dx.doi.org/10.4161/epi.24823; PMID: 23764768
   PubMed Web of Science ®Google Scholar
• Juhlin CC, Kiss NB, Villablanca A, Haglund F, Nordenström J, Höög A, Larsson C. Frequent promoter hypermethylation of the APC and RASSF1A tumour suppressors in parathyroid tumours. PLoS One 2010; 5:e9472; http://dx.doi.org/10.1371/journal.pone.0009472; PMID: 20208994
   PubMedGoogle Scholar
• Bustin SA, Benes V, Garson JA, Hellemans J, Huggett J, Kubista M, Mueller R, Nolan T, Pfaffl MW, Shipley GL, et al. The MIQE guidelines: minimum information for publication of quantitative real-time PCR experiments. Clin Chem 2009; 55:611 - 22; http://dx.doi.org/10.1373/clinchem.2008.112797; PMID: 19246619
   PubMed Web of Science ®Google Scholar